A detailed history of Northwestern Mutual Wealth Management CO transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 40 shares of RNA stock, worth $1,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Holding current value
$1,186
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$37.21 - $48.14 $1,488 - $1,925
40 New
40 $1,000
Q4 2022

Feb 21, 2023

BUY
$10.06 - $22.66 $30 - $67
3 New
3 $0
Q2 2022

Aug 04, 2022

BUY
$11.18 - $20.5 $156 - $287
14 New
14 $0
Q1 2022

May 09, 2022

SELL
$14.2 - $23.78 $71 - $118
-5 Closed
0 $0
Q4 2021

Feb 03, 2022

BUY
$20.4 - $28.66 $102 - $143
5 New
5 $0

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.55B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.